// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Stakeholder Perceptions on the Roles ClinicalNeuropsychologists Can Play in Rehabilitation Service Delivery forVictims of a Traumatic Brain Injury with Mental Health Disorders.

M. DESJARDINS - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Usefulnessof the Rivermead Post-Concussion Symptoms Questionnaire forOutcome Prediction in Patients with Mild Traumatic Brain Injury.

S. BELANGER - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Neuropsychological Impact of Repeated Sub-Concussive Blowsto the Head in Male and Female Athletes.

E. CHAMARD - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective MemoryFollowing Traumatic Brain Injury: A Meta-Analysis.

L. BUCHANAN - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

White matter long-term abnormalities in the corpus callosum offemale concussed athletes.

G. LEFEBVRE - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Preliminary Evaluationof the Diagnostic Utility of Diffusion Tensor Imaging (DTI) forDetecting Mild Traumatic Brain Injury (mTBI) in Spinal CordInjury (SCI) Patients.

Y. KOSHIMORI - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Recovery of Variability in Attention Task Performanceafter Moderate-Severe Traumatic Brain Injury.

B. COLELLA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

The Role of Stress and Emotion Regulation in Post-ConcussiveSymptom Reporting in Healthy Adults.

B. ZUCCATO - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Objective& Subjective Sleep Quality Differentially Relate to Depressive,Cognitive, and Cognitive-Affective Processes in an ObstructiveSleep Apnea Referral.

C.M. CONSIDINE - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Diagnostic Uncertainty and Speculations Regarding MildTraumatic Brain Injury (mTBI): Diffusion Tensor Imaging (DTI)Versus Conventional Neuroimaging.

B. SHARMA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

CognitiveHypothesis Testing for Targeted Reading Disability SubtypeInterventions: Impact on Reading Competency and White MatterConnectivity.

J.B. HALE - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association Between Executive Functions and Loneliness Acrossthe Adult Lifespan.

M. COCHRANE - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Olfactoryand Executive Dysfunctions Following Orbito-basal Lesions inTraumatic Brain Injury.

A. ALTURKI - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Examination of the bilingual advantage in young adults using twobehavioral rating scale measures of executive function.

E.C. DUGGAN - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ExaminingExecutive Behavior of Young Adults: Convergent Validity Analysesof an Executive Functions Screener.

M.A. GARCIA-BARRERA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Using the Automatized Sequences Task as a performance validitytest in youth with neurological diagnoses.

H. DAYA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Influenceof Physical and Mental Health on Long-Term Cognitive TrainingIntervention Outcomes.

J. Jones - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Association between GlobalHealth Habits and Cognitive Function in Non-Demented OlderAdults.

A.J. FIOCCO - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhibitory Control Underlies Recollectionand Reconstruction Processes in Older Adult- HindsightJudgments.

E. ERDFELDER - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

GeneticRisk for Executive Function Decline in Non-Demented Aging isAssociated with APOE and Selectively Intensified by BDNF andCOMT.

G. MCFALL - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved